Durham, NC, United States of America

Hannah Reid Hudson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The General Hospital Corporation, The University of North Carolina at Chapel Hill. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hannah Reid Hudson. Retrieved from https://idiyas.com/inventor/hannah-reid-hudson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hannah Reid Hudson

Introduction

Hannah Reid Hudson is a prominent inventor based in Durham, NC (US). She has made significant strides in the field of cancer treatment through her innovative research and development of chimeric antigen receptors.

Latest Patents

Hannah Reid Hudson holds a patent for "Methods and compositions for chimeric antigen receptor targeting cancer cells." This invention provides a chimeric antigen receptor (CAR) that recognizes CSPG4, along with methods of use in the treatment of various diseases and disorders. Her work is pivotal in advancing therapeutic options for cancer patients.

Career Highlights

Throughout her career, Hannah has been associated with esteemed institutions such as the University of North Carolina at Chapel Hill and The General Hospital Corporation. Her contributions to research and development in the medical field have been recognized and valued.

Collaborations

Hannah has collaborated with notable professionals in her field, including Gianpietro Dotti and Soldano Ferrone. These partnerships have further enhanced her research and the impact of her inventions.

Conclusion

Hannah Reid Hudson's innovative work in developing chimeric antigen receptors represents a significant advancement in cancer treatment. Her dedication to research and collaboration continues to inspire progress in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…